The Cannabis Company That Won't Mix Work With Pleasure
A limited supply of cannabis in the U.S. means those resources have to be divvied up carefully.
For Cronos Group, that means keeping its medical and recreational marijuana operations in completely different verticals, CEO Michael Gorenstein told Cheddar. That ensures patients’ needs are prioritized over those of recreational users.
“If you think about building a town, and you have a limited amount of building supplies, we want to make sure that we’re building a hospital before we’re building the bar,” he said.
Canada-based Cronos Group started trading on the NASDAQ on Tuesday, making it the first marijuana company to list on a major U.S. market.
“It’s a big milestone not just for us but for the entire industry,” said Gorenstein. “[It] just continues to show the acceptance that the cannabis industry is getting.”
And the industry does seem to be growing at break-neck speed. Arcview, a leading researcher of the cannabis market, stated in a [recent report](https://arcviewgroup.com/product/5th-edition/) that the industry brought in $9.7 billion in sales in 2017, and that number could grow to over $25 billion by 2021.
For the full interview, [click here](https://cheddar.com/videos/inside-the-first-cannabis-company-to-list-on-nasdaq).
A stacked week of earnings this week as Facebook, Twitter, Amazon and several others gear up to release their quarterly results. Earnings have so far exceeded expectations despite supply chain concerns and the ongoing pandemic. Daniel Newman, Futurum Research principal analyst, tells Cheddar which companies he's paying attention to this week.
Ali Parsa, Founder & CEO of Babylon, discusses the need for healthcare monitoring to prevent sickness and how technology improves access to quality care.
The FDA meets today on whether or not vaccines for children ages 5-11 can potentially become available to the public. Cheddar News was joined by Dr. Richard Besser, President and CEO of the Robert Wood Johnson Foundation and former Acting Director of the CDC to discuss what could come next for these vaccines.
Last week, shares of Digital World Acquisition Corp skyrocketed after following Former Present Trump's announcement that he would be partnering with the company as part of a Special Purpose Acquisition Company, or SPAC. Christian Munafo, Chief Investment Officer of Liberty Street Advisors and portfolio Manager of the Private Shares Fund broke down the latest, including whether or not Wall Street is currently experiencing a SPAC boom.
Philip Palumbo, Founder, CEO, and CIO at Palumbo Wealth Management, joined Wake Up With Cheddar to break down what's moving the markets ahead of a huge week of tech earnings.
Facebook reported a beat on its Q3 earnings on Monday, despite a miss on revenue. This comes as the social media giant has found itself entrenched in negative headlines of late. Timothy Lesko, Partner and Portfolio Manager at Granite Investment Advisors, joined Cheddar to break down the latest.
Facebook has been in the midst of a media firestorm thanks to the Wall Street Journal scathing report and Frances Haugen's whistleblowing among other news. With the social media giant set to release its Q3 earnings after the bell, Cheddar News caught up with John Quelch, Dean of Miami Herbery Business School to discuss what to expect.
Jill and Carlo cover the news out of Facebook's latest earnings, Tesla's monumental day, Dave Chappelle addresses controversy and the tragedy of the climate emergency.
